All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

35

Reset

35 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BrenipatideLY3537031Phase 313 trials

    Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major

  • AzetukalnerXEN1101Phase 39 trials

    Xenon Pharmaceuticals Inc. · Focal Onset Seizures, Major Depressive Disorder, Bipolar Disorder

  • SEP-363856UlotarontPhase 37 trials

    Otsuka · Generalized Anxiety Disorder, Schizophrenia, Major Depressive Disorder

  • BHV-7000Phase 36 trials

    Biohaven Therapeutics Ltd. · Focal Epilepsy, Major Depressive Disorder, Bipolar Disorder

  • NBI-1065845TAK-653, OsavampatorPhase 35 trials

    Neurocrine Biosciences · Major Depressive Disorder

  • CYM-53093Navacaprant, NMRA-335140Phase 34 trials

    Neumora Therapeutics, Inc. · Major Depressive Disorder, Major Depressive Episode Associated With Bipolar II Disorder

  • DT120MM120, lysergide tartratePhase 34 trials

    Definium Therapeutics US, Inc. · Generalized Anxiety Disorder, Major Depressive Disorder

  • KH607Phase 34 trials

    Chengdu Kanghong Pharmaceutical Group Co., Ltd. · Major Depressive Disorder (MDD), Postpartum Depressive Disorder

  • PsilocybinCOMP360Phase 34 trials

    COMPASS Pathways · Treatment Resistant Depression, Major Depressive Disorder, Anorexia Nervosa

  • CYB003Phase 33 trials

    Cybin IRL Limited · Major Depressive Disorder, Major Depressive Disorder (MDD), Depression in Adults

  • SeltorexantJNJ 42847922Phase 32 trials

    Johnson & Johnson (Janssen) · Depressive Disorder, Major

  • CSPC Ouyi Pharmaceutical Co., Ltd. · Major Depressive Disorder (MDD)

  • ONO-1110Phase 25 trials

    Ono Pharmaceutical Co., Ltd. · Fibromyalgia, Social Anxiety Disorder (SAD), Major Depressive Disorder (MDD

  • ABX-002Phase 22 trials

    Autobahn Therapeutics, Inc. · Major Depressive Disorder, Bipolar Disorder Depression

  • BI 1569912Phase 22 trials

    Boehringer Ingelheim · Depressive Disorder, Major

  • DT-101Phase 22 trials

    Draig Therapeutics Ltd · Major Depressive Disorder (MDD)

  • IcalcaprantABBV-1354, CVL-354Phase 22 trials

    AbbVie · Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder

  • SPT-300LYT-300, GlyphAlloPhase 22 trials

    Seaport Therapeutics · Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress

  • ZelquistinelGATE-251Phase 22 trials

    Syndeio Biosciences, Inc · Major Depressive Disorder

  • ACP-211Phase 21 trial

    ACADIA Pharmaceuticals Inc. · Major Depressive Disorder (MDD), Depressive Disorder, Treatment-Resistant

  • ALTO-100Phase 21 trial

    Alto Neuroscience · Bipolar Disorder I or II With a Major Depressive Episode

  • ALTO-203Phase 21 trial

    Alto Neuroscience · Major Depressive Disorder, Anhedonia

  • ALTO-300Phase 21 trial

    Alto Neuroscience · Major Depressive Disorder

  • BMS-986511EvifacotrepPhase 21 trial

    Bristol Myers Squibb · Major Depressive Disorder

  • CLE-100Phase 21 trial

    Clexio Biosciences Ltd. · Adjunctive Treatment of Major Depressive Disorder (MDD)

  • ELE-101Phase 21 trial

    Eleusis Therapeutics · Healthy Volunteers, Major Depressive Disorder, Depression

  • GM-1020Phase 21 trial

    Gilgamesh Pharmaceuticals · Major Depressive Disorder

  • GM-2505Phase 21 trial

    AbbVie · Major Depressive Disorder

  • JNJ-89495120Phase 21 trial

    Johnson & Johnson (Janssen) · Depressive Disorder, Major

  • NBI-1070770Phase 21 trial

    Neurocrine Biosciences · Major Depressive Disorder

  • NH102Phase 21 trial

    Jiangsu Nhwa Pharmaceutical Co., Ltd. · Major Depressive Disorder (MDD)

  • PDC-1421Phase 21 trial

    BioLite, Inc. · Major Depressive Disorder

  • PRT042Phase 21 trial

    Sichuan Purity Pharmaceutical Technology Co., Ltd. · Major Depressive Disorder (MDD

  • SP-624Phase 21 trial

    Sirtsei Pharmaceuticals, Inc. · Major Depressive Disorder

  • SPN-821Phase 21 trial

    Supernus Pharmaceuticals, Inc. · Major Depressive Disorder (MDD)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.